Weekly paclitaxel (wP) as single agent or in combination with weekly topotecan (wT) or carboplatin (C) in patients with resistant ovarian cancer (ROC): The phase II CARTAXHY randomized trial from GINECO

Authors
Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2009
This article has no abstract
Epistemonikos ID: 9f7f8b97cb833d6569c9d7309925eaea2250d271
First added on: Mar 01, 2025